Skip to Main Content

Author Details

Bogdan Czerniak
University of Texas MD Anderson Cancer Center
1975
228
55
PMIDPaper TitleJournal TitlePublished Year
34789422Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.Eur Urol Oncol2023
37662238Combined Mek inhibition and <i>Pparg</i> activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced Carcinogenesis.bioRxiv2023
37833193Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.Eur Urol Oncol2023
37037612Pre-cancer: From diagnosis to intervention opportunities.Cancer Cell2023
37099409Intraosseous hibernoma: clinicopathologic and imaging analysis of 18 cases.Histopathology2023
36890027Reprint of: somatic-type malignancies in testicular germ cell tumors.Hum Pathol2023
34334690Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases.Am J Surg Pathol2022
35847448Lentiviral interferon: A novel method for gene therapy in bladder cancer.Mol Ther Oncolytics2022
35803413Somatic-type malignancies in testicular germ cell tumors.Hum Pathol2022
35379845MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.Nat Commun2022
35467000Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma.Am J Clin Pathol2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
35811851Erratum: The origin of bladder cancer from mucosal field effects.iScience2022
35961847Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.Urol Oncol2022
36344183Molecular Taxonomy and Immune Checkpoint Therapy in Bladder Cancer.Surg Pathol Clin2022
34514028Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer.Mol Ther Methods Clin Dev2021
33881933Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.J Urol2021
33563539Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.Urol Oncol2021
345566689p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.Nat Commun2021
32253420Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.Am J Clin Pathol2020
32037144Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.Eur Urol2020
32062474Cardiac paragangliomas: A case series with clinicopathologic features and succinate dehydrogenase B immunostaining.Ann Diagn Pathol2020
33247183Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy.Commun Biol2020
33449546Total Tibial Allograft Reconstruction for Adamantinoma: A Case Report With 2-Year Follow-up.JBJS Case Connect2020
32836180Secondary tumors of the bladder: A survival outcome study.Ann Diagn Pathol2020
32122956TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.Mol Cancer Res2020
32546765Assessment of Luminal and Basal Phenotypes in Bladder Cancer.Sci Rep2020
32521509Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.iScience2020
29428551Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.Eur Urol Focus2019
31582354Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study.Lancet Oncol2019
30777393Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.Urol Oncol2019
30784602Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.Cell Rep2019
30672335Bladder Cancer in the Genomic Era.Arch Pathol Lab Med2019
28827100Carcinoma of the urethra.Hum Pathol2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
29854012Urine cell-based DNA methylation classifier for monitoring bladder cancer.Clin Epigenetics2018
28429277Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases.Pathol Oncol Res2018
29763719Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.Hum Pathol2018
27494900Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis.Oncotarget2017
28102366Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.Sci Rep2017
28371875Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases.Am J Clin Pathol2017
28988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017
28601352Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.Eur Urol2017
28753816Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.Eur Urol Focus2017
28823575High-grade neuroendocrine carcinoma of the urachus-report of 3 cases.Hum Pathol2017
28710314Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.Clin Cancer Res2017
27753185Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.BJU Int2017
26907529Origins of Bladder Cancer.Annu Rev Pathol2016
26272062Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.Clin Cancer Res2016
26536169Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.N Engl J Med2016
  • 1 - 50 of 228

Recommended Authors

Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 10
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 2
Adeboye O Osunkoya
Emory University School of Medicine
Career Start Year 2002
Number of shared co-authors 5
Rohit Mehra
Michigan Center for Translational Pathology.
Career Start Year 2000
Number of shared co-authors 33
Anuradha Gopalan
Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 13
Jaime Ferrer
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 3
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 1
Amy Ziober
Hospital of the University of Pennsylvania
Career Start Year 1995
Number of shared co-authors 1
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 3
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 2
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 14
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 4
Juan P Palazzo
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 6
Pedram Argani
The Johns Hopkins Hospital
Career Start Year 1987
Number of shared co-authors 10
Cyril B Gilks
University of British Columbia
Career Start Year 1987
Number of shared co-authors 15
Peter A Humphrey
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 10
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 2
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 2
Rex C Bentley
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 4
Gary L Keeney
Mayo Clinic
Career Start Year 1984
Number of shared co-authors 8
Jos?? Palacios
Universidad de Alcala
Career Start Year 1983
Number of shared co-authors 5
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 7
Adel K El-Naggar
MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 38
Jahn M Nesland
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 0
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 5
Cathy Corbishley
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 3
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 13
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 12
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 3
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 23

Collaborators

Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 62
David J McConkey
Johns Hopkins School of Medicine
Co-authored papers 34
Jolanta Bondaruk
The University of Texas MD Anderson Cancer Center
Co-authored papers 30
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 28
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 18
Philippe E Spiess
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 12
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Surena F Matin
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
David Cogdell
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Steven E Scherer
Baylor College of Medicine
Co-authored papers 6
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 5
Jean-Pierre J Issa
Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine
Co-authored papers 5
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 4
Kevin R Coombes
Medical College of Georgia
Co-authored papers 4
Alan Pollack
University of Miami Miller School of Medicine
Co-authored papers 4
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 4
Subrata Sen
UT MD Anderson Cancer Center
Co-authored papers 4
Eleni Efstathiou
Houston Methodist Cancer Center
Co-authored papers 4
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 4
Matthew Meyerson
Broad Institute
Co-authored papers 3
Linghua Wang
The University of Texas M. D. Anderson
Co-authored papers 3
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers 3
Yu Shen
Co-authored papers 3
Kenneth Aldape
National Cancer Institute
Co-authored papers 3
Mauro A A Castro
Federal University of Parana
Co-authored papers 3
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Jaegil Kim
Co-authored papers 3
Lambertus A Kiemeney
Co-authored papers 3
Release 1.2